- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/08 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
Patent holdings for IPC class C07D 215/08
Total number of patents in this class: 118
10-year publication summary
|
8
|
11
|
7
|
7
|
10
|
9
|
3
|
5
|
2
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3522 |
9 |
| Sanofi | 4319 |
6 |
| Conopco, Inc. | 5092 |
4 |
| Sumitomo Chemical Company, Limited | 8968 |
4 |
| Lead Pharma Holding B.V. | 20 |
4 |
| Bristol-myers Squibb Company | 4757 |
3 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| Board of Regents, The University of Texas System | 6141 |
3 |
| Cytokinetics, Inc. | 251 |
3 |
| F. Hoffmann-La Roche AG | 7808 |
2 |
| Unilever PLC | 2985 |
2 |
| Unilever N.V. | 2899 |
2 |
| President and Fellows of Harvard College | 6105 |
2 |
| Northwestern University | 3557 |
2 |
| Astex Therapeutics Limited | 207 |
2 |
| Constellation Pharmaceuticals, Inc. | 218 |
2 |
| Fondazione Istituto Italiano di Tecnologia | 632 |
2 |
| Indiana University Research and Technology Corporation | 782 |
2 |
| SABIC Global Technologies B.V. | 4611 |
2 |
| Vilnius University | 100 |
2 |
| Other owners | 57 |